Fr Vla News Today

By Stephen Nakrosis The Food and Drug Administration said it granted approval of Ixchiq, the first vaccine for chikungunya virus, to Valneva Austria. Valneva...

By Andrea Figueras Valneva reported a narrowed loss for the first half, thanks to sharply reduced costs that offset a decline in revenue due to the effects...

By Cecilia Butini Valneva has received positive safety data in a Phase 3 trial studying a vaccine against the mosquito-borne chikungunya virus. Data showed...

By Adria Calatayud Valneva said it will receive up to $100 million in additional financing and that it will use the funds to invest in research and...

By Maitane Sardon Valneva said Monday that the U.S. Food and Drug Administration has delayed the target date for completing the regulatory review of the...

By Maitane Sardon Shares in Valneva plunged in early trading Monday after the French biotech company said the U.S. Food and Drug Administration has delayed...